Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/14/2025

Managing Nausea from Vancomycin

First-Line Treatment Options

  • The National Comprehensive Cancer Network recommends dopamine receptor antagonists, such as metoclopramide (10-20 mg PO/IV every 6 hours) or prochlorperazine (5-10 mg PO/IV every 6 hours), as first-line treatment for nausea from vancomycin 1, 2

Second-Line Treatment Options

  • The National Comprehensive Cancer Network suggests adding a 5-HT3 receptor antagonist, such as ondansetron (4-8 mg PO/IV every 8-12 hours), if nausea persists despite first-line treatment 1, 4, 5

Refractory Nausea Management

  • The National Comprehensive Cancer Network recommends considering adding a corticosteroid, such as dexamethasone (4-8 mg PO/IV daily), for persistent nausea 4, 2
  • Olanzapine (2.5-5 mg PO or sublingual every 6-8 hours) is particularly effective for refractory nausea 3

Administration Tips

  • The National Comprehensive Cancer Network suggests scheduling antiemetics around-the-clock rather than as-needed for persistent nausea 1, 2
  • Starting with lower doses of olanzapine (2.5 mg) in elderly or debilitated patients can minimize sedation 3

Common Pitfalls and Caveats

  • Monitoring for extrapyramidal symptoms with metoclopramide, especially at higher doses, is crucial 2
  • Being aware of potential sedation with antihistamines and olanzapine is important 3
  • 5-HT3 antagonists can cause constipation, which may worsen overall comfort 2
  • If the patient is on opioids, considering opioid rotation as persistent nausea may be opioid-induced is necessary 1, 2

REFERENCES

1

palliative care version 1.2016. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

2

Treatment for Unretractable Nausea [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

nccn clinical practice guidelines in oncology: palliative care. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2009

5

Management of Persistent Nausea After Ondansetron and Promethazine [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025